Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Healthcare
Zentalis Pharmaceuticals, Inc. Revenue 2022–2025
Zentalis Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Zentalis Pharmaceuticals, Inc. revenue for the quarter ending September 30, 2025 was 0.
- Zentalis Pharmaceuticals, Inc. revenue for the twelve months ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Zentalis Pharmaceuticals, Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Zentalis Pharmaceuticals, Inc. annual revenue for 2024 was 67.4 M.
- Zentalis Pharmaceuticals, Inc. annual revenue for 2023 was 0.
- Zentalis Pharmaceuticals, Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Zentalis Pharmaceuticals, Inc. Market Cap — FAQ
Zentalis Pharmaceuticals, Inc. (ZNTL) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZNTL's market cap history?
The chart and table above show Zentalis Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.